https://scholars.lib.ntu.edu.tw/handle/123456789/630701
標題: | Patient-reported outcomes among virally suppressed people living with HIV after switching to Co-formulated bictegravir, emtricitabine and tenofovir alafenamide | 作者: | Chen, Ling-Ya HSIN-YUN SUN YU-CHUNG CHUANG YU-SHAN HUANG WANG-DA LIU KUAN-YIN LIN Chang, Hsi-Yen Luo, Yu-Zhen Wu, Pei-Ying Su, Yi-Ching Liu, Wen-Chun CHIEN-CHING HUNG |
關鍵字: | Adverse effect; HIV Symptom index; Integrase strand-transfer inhibitor; Quality of life; Viral suppression | 公開日期: | 9-二月-2023 | 來源出版物: | Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi | 摘要: | While some evidence has suggested the benefits of co-formulated bictegravir, emtricitabine and tenofovir alafenamide (B/F/TAF) in improving the quality of life of people living with HIV (PLWH), patient-reported outcome studies that focus on Asian population remain scarce. We aimed to determine the changes in HIV-related symptom burden in virally-suppressed PLWH switching to B/F/TAF in a real-world setting. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/630701 | ISSN: | 16841182 | DOI: | 10.1016/j.jmii.2023.01.015 |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。